PsyBio Therapeutics Corp. (PSYBF)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Nov 17, 2026
PsyBio Therapeutics Market Cap
PsyBio Therapeutics has a market cap or net worth of $133 as of November 19, 2026. It is the 52,950th most valuable company in the world and the 8,847th biggest in the United States. Its market cap has decreased by 89.97% in one year.
Market Cap
133.00
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#8,847 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since April 23, 2021, PsyBio Therapeutics's market cap has decreased from 38.24M to 133.00, a decrease of -100.00%. That is a compound annual growth rate of -89.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 133.00 | - |
| Dec 22, 2025 | 133.00 | - |
| Dec 5, 2024 | 133.00 | -99.98% |
| Dec 29, 2023 | 583.50K | -80.15% |
| Dec 30, 2022 | 2.94M | -83.74% |
| Dec 31, 2021 | 18.07M | -52.73% |
| Apr 23, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NanoLogix | 163.00 |
| Kiromic BioPharma | 157.00 |
| Regenicin | 153.00 |
| Immage Biotherapeutics | 152.00 |
| Poniard Pharmaceuticals | 150.00 |
| LadRx | 149.00 |
| NexImmune | 139.00 |
| Marizyme | 132.00 |